Met Life Investment Management, LLC Sangamo Therapeutics, Inc Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$1.11 - $1.74 $75,455 - $118,281	67,978 New	67,978 $88,000
Q1 2023 May 09, 2024	BUY	$1.66 - $3.67 $112,843 - $249,479	67,978 New	67,978 $120 Million
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $21,422 - $47,361	12,905 Added 23.43%	67,978 $119,000
Q4 2022 May 10, 2024	SELL	$2.77 - $5.07 $32,577 - $59,628	-11,761 Reduced 17.6%	55,073 $172,000
Q4 2022 Jun 14, 2023	SELL	$2.77 - $5.07 $35,746 - $65,428	-12,905 Reduced 18.98%	55,073 $172,000
Q4 2022 Mar 22, 2023	SELL	$2.77 - $5.07 $32,577 - $59,628	-11,761 Reduced 17.6%	55,073 $172,000
Q4 2022 Feb 15, 2023	SELL	$2.77 - $5.07 $32,577 - $59,628	-11,761 Reduced 17.6%	55,073 $172,000
Q3 2022 Jun 14, 2023	SELL	$4.27 - $6.39 $4,884 - $7,310	-1,144 Reduced 1.68%	66,834 $327,000
Q2 2022 May 10, 2024	BUY	$3.28 - $6.21 $23,504 - $44,500	7,166 Added 12.01%	66,834 $276,000
Q2 2022 Jun 20, 2023	SELL	$3.28 - $6.21 $3,752 - $7,104	-1,144 Reduced 1.68%	66,834 $276,000
Q2 2022 Mar 22, 2023	BUY	$3.28 - $6.21 $23,504 - $44,500	7,166 Added 12.01%	66,834 $276,000
Q2 2022 Aug 11, 2022	BUY	$3.28 - $6.21 $23,504 - $44,500	7,166 Added 12.01%	66,834 $277,000
Q1 2022 May 10, 2024	BUY	$5.23 - $7.82 $312,063 - $466,603	59,668 New	59,668 $346,000
Q1 2022 Jun 20, 2023	SELL	$5.23 - $7.82 $43,461 - $64,984	-8,310 Reduced 12.22%	59,668 $346,000
Q1 2022 Mar 22, 2023	BUY	$5.23 - $7.82 $78,957 - $118,058	15,097 Added 33.87%	59,668 $346,000
Q1 2022 May 12, 2022	BUY	$5.23 - $7.82 $78,957 - $118,058	15,097 Added 33.87%	59,668 $347,000
Q4 2021 Jun 21, 2023	SELL	$7.29 - $10.97 $170,637 - $256,774	-23,407 Reduced 34.43%	44,571 $334,000
Q3 2021 Jun 21, 2023	SELL	$9.01 - $12.01 $210,897 - $281,118	-23,407 Reduced 34.43%	44,571 $401,000
Q2 2021 Jun 21, 2023	SELL	$10.17 - $12.64 $238,049 - $295,864	-23,407 Reduced 34.43%	44,571 $533,000
Q1 2021 May 17, 2024	BUY	$10.88 - $17.05 $484,932 - $759,935	44,571 New	44,571 $558,000
Q1 2021 Jun 26, 2023	SELL	$10.88 - $17.05 $254,668 - $399,089	-23,407 Reduced 34.43%	44,571 $558 Million
Q1 2021 Mar 22, 2023	SELL	$10.88 - $17.05 $90,924 - $142,486	-8,357 Reduced 15.79%	44,571 $558,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $90,924 - $142,486	-8,357 Reduced 15.79%	44,571 $558,000
Q4 2020 Jun 22, 2023	SELL	$9.23 - $18.18 $138,911 - $273,609	-15,050 Reduced 22.14%	52,928 $826,000
Q3 2020 Jun 26, 2023	SELL	$9.38 - $12.48 $141,169 - $187,824	-15,050 Reduced 22.14%	52,928 $500,000
Q2 2020 May 24, 2024	BUY	$6.21 - $11.83 $328,682 - $626,138	52,928 New	52,928 $474 Million
Q2 2020 Jun 26, 2023	SELL	$6.21 - $11.83 $93,460 - $178,041	-15,050 Reduced 22.14%	52,928 $474,000
Q1 2020 Jul 12, 2023	SELL	$5.05 - $8.85 $76,002 - $133,192	-15,050 Reduced 22.14%	52,928 $337,000
Q4 2019 Jul 12, 2023	SELL	$8.03 - $11.7 $120,851 - $176,085	-15,050 Reduced 22.14%	52,928 $443,000
Q3 2019 Jul 12, 2023	SELL	$9.05 - $12.22 $136,202 - $183,911	-15,050 Reduced 22.14%	52,928 $478,000
Q3 2019 Mar 22, 2023	BUY	$9.05 - $12.22 $52,227 - $70,521	5,771 Added 12.24%	52,928 $478,000
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $52,227 - $70,521	5,771 Added 12.24%	52,928 $479,000
Q2 2019 Jul 12, 2023	SELL	$8.75 - $13.03 $131,687 - $196,101	-15,050 Reduced 22.14%	52,928 $570,000
Q1 2019 Jul 13, 2023	SELL	$7.72 - $12.81 $160,738 - $266,717	-20,821 Reduced 30.63%	47,157 $449,000
Q4 2018 Jul 13, 2023	SELL	$9.51 - $16.6 $198,007 - $345,628	-20,821 Reduced 30.63%	47,157 $541,000
Q4 2018 Mar 22, 2023	SELL	$9.51 - $16.6 $247,345 - $431,749	-26,009 Reduced 35.55%	47,157 $541,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $247,345 - $431,749	-26,009 Reduced 35.55%	47,157 $541,000
Q3 2018 Jul 13, 2023	SELL	$13.05 - $19.05 $271,714 - $396,640	-20,821 Reduced 30.63%	47,157 $799,000
Q3 2018 Mar 22, 2023	BUY	$13.05 - $19.05 $236,113 - $344,671	18,093 Added 32.85%	73,166 $1.24 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $339,417 - $495,471	26,009 Added 55.15%	73,166 $1.24 Million
Q2 2018 Aug 15, 2018	BUY	$13.9 - $19.8 $110,796 - $157,825	7,971 Added 20.34%	47,157 $670,000
Q4 2017 Feb 15, 2018	BUY	$11.6 - $17.35 $454,557 - $679,877	39,186	39,186 $643,000

Others Institutions Holding SGMO

# of Institutions

133

Shares Held

86.3M

Call Options Held

35.9K

Put Options Held

156K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$17.5 Million
0.04% of portfolio
Armistice Capital, LLC New York, NY

14.1M
Shares

$12.2 Million
0.07% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$4.09 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.56M
Shares

$3.97 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account